Protagenic Therapeutics News

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

AccesswireOct 29 21:27

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

BenzingaSep 12 17:46

10-Q: Q2 2024 Earnings Report

SECAug 15 05:01 · Announcements

Express News | Protagenic Therapeutics Inc Files for Mixed Shelf Offering of up to $100 Mln- SEC Filing

BreakingsJun 15 05:32

Jaguar Health, Altamira Therapeutics,Erasca Among Healthcare Movers

Seeking AlphaMay 23 22:04

Protagenic Therapeutics pressure-regulating peptides showed excellent safety in the single-dose portion of the Phase I trial

Protagenic Therapeutics pressure-regulating peptides showed excellent safety in the single-dose portion of the Phase I trial

Zhitong FinanceMay 22 21:19

Express News | Protagenic Therapeutics Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial

BreakingsMay 22 21:17

Protagenic Therapeutics' Reports Safety Data From Single Dose Portion Of Phase 1 Trial Involving PT00114

BenzingaMay 22 21:03

Protagenic Therapeutics' Stress-Regulating Peptide Demonstrates Exceptional Safety in Single Dose Portion of Phase I Trial, Paving the Way for Next Steps Toward Potential Breakthrough Treatments in Stress Related Neuropsychiatric Disorders

Yahoo FinanceMay 22 20:12

10-Q: Q1 2024 Earnings Report

SECMay 16 04:44 · Announcements

10-K/A: Annual report (Amendment)

SECMay 14 18:09 · Announcements

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

AccesswireMay 1 20:38

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaApr 26 20:06

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaApr 26 00:31

KOPN, BTCM and CETX Among Mid-day Movers

Seeking AlphaApr 24 01:16

Protagenic Therapeutics' Peptide PT00114 To Be Highlighted At Boston Summit In Presentation Titled "Novel Blood-Brain Barrier Penetrating Peptide: Opening New Doors in Neuro-Psychiatric Treatment" On April 23, 2024

BenzingaApr 17 20:47

Earnings Call Summary | Protagenic Therapeutics(PTIX.US) Q4 2023 Earnings Conference

Futu NewsApr 2 10:18 · Conference Call

Protagenic Therapeutics FY23 EPS $(1.15) Down From $(0.82) YoY

BenzingaApr 2 04:24

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

AccesswireApr 2 04:20

Earnings Scheduled For April 1, 2024

BenzingaApr 1 17:13